(1)
Rajpoot, M.; Singh, D.; Pandey, K. .; Bhargava, R. Safety and Efficacy of Cyclosporine (0.05% Versus 0.09%) in Dry Eye Disease. Is It the Strength of Cyclosporin That Really Matters? . Nep J Oph 2022, 14 (2), 64-77. https://doi.org/10.3126/nepjoph.v14i2.38928.